Please login to the form below

Not currently logged in
Email:
Password:

PR and Med Ed news in brief

Our weekly round up of healthcare PR stories

J&J linked with Olympic sponsorship deal

Speculation is mounting that Johnson & Johnson is set to become a top-tier sponsor of the Olympic Games. The US pharma company is expected to sign a £100m deal with the International Olympic Committee after the completion of the 2006 Winter Games in Turin next February. The deal would allow J&J to use the famous Olympic Rings trademark across all its products and have an exclusive presence at future Games up until at least the London Games in 2012.

Galliard wins GSK Avodart contract

Galliard Healthcare Communications has won the global PR contract for GlaxoSmithKline's (GSK) benign prostatic hyperplasia treatment Avodart. The London-based agency beat off competition from Edelman and Ketchum to replace Fleishman-Hillard, which declined to repitch for the account citing a conflict of interest. Galliard managing director Marika Freris will lead a four-strong team on the account, reporting to GSK's global scientific communications strategy team. GSK is currently investigating Avodart's use in the prevention of prostate cancer, a potentially lucrative market if it succeeds in clinical trials.

2nd September 2008

Share

] [PR and Med Ed news in brief, Our weekly round up of healthcare PR stories, News Article, , ,] -->

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles Medical Communications

Quintiles’ award-winning medical communications group sits at the heart of the enterprise. We offer a range of innovative strategic services,...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics